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The effects of mefloquine, a quinoline-4-methanol antimalarial drug, on respiration by various bacterial 
strains endowed with branched electron transport pathways, have been examined. It is concluded that mef- 
loquine strongly interacts with cytochrome 6 in the b/c segment of the chain. Unlike myxothiazol, meflo- 
quine does not inhibit oxidant-induced b-type reduction but does induce an extra cytochrome b reduction 
when used in combination with antimycin A. The data reported are interpreted as evidence that mefloquine 
inhibits a ubiquinol oxidase site in common to both the alternative oxidase and the b/c oxidoreductase com- 
plex of the chain. 
Mejloquine Electron transport Alternative oxidase Rhodopseudomonas capsulata 
Rhodopseudomonas sphaeroides Pseudomonas cichorii 
1. INTRODUCTION 
Mefloquine (fig.1) is a quinolmethanol blood 
schizontocide which is highly effective against 
drug-resistant as well as drug-sensitive 
Plasmodium vivax and Plasmodium falciparum, 
has a high therapeutic index and has been accepted 
for clinical use (review 111). Mefloquine is also 
bactericidal, and causes exponential oss of viabili- 
ty in cultures of Escherichia coli 121. Loss of 
viability is accompanied by decrease in turbidity 
which suggests lytic properties of mefloquine. 
Mefloquine (MEF) binds to both phospholipids 
and iron porphyrin components such as 
J* 
o?- 
0 0 “=’ CF3 
CF3 
MEROQUINE ~w~~42mo~ 
Fig.1. The structure of mefloquine (WR 142,490). DL- 
erythro-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quino- 
linemethanol hydrochloride. 
plasmodial hemozoin [3,4] and affects the integrity 
of E. coli inner membrane in which has been pro- 
posed to inhibit NADH oxidation through interac- 
tion with membrane-bound b-type cytochromes 
[5]. This latter hypothesis has been verified and 
more thoroughly analyzed here by examining the 
effects of mefloquine on various bacterial 
respiratory chains. 
2. MATERIALS AND METHODS 
Mefloquine was a gift from Dr A.D. Wolfe 
(Walter Reed Army Institute of Research, 
Washington DC). The bacterial species used in this 
investigation were Pseudomonas cichorii, 
Rhodopseudomonas capsulata MR126 and 
Rhodopseudomonas sphaeroides R26 [6-81. 
Aerobic cultures of R. capsulata MR126 were ob- 
tained as described [7] using a synthetic medium 
containing malate [9]. R. sphaeroides R26 was 
grown photosynthetically in the same medium sup- 
plemented with yeast extract (Difco, 2 g/l). P. 
cichorii was grown aerobically as described by 
Zannoni [6]. Plasma membrane fragments were 
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prepared according to standard procedures [6]. 
Ubiquinones were reduced to ubiquinols as in [lo]. 
Rates of oxygen consumption were measured 
polarographically at 30°C with a Clark oxygen 
electrode. 2,6-Dichlorophenolindophenol (DCIP), 
cytochrome c and ubiquinone-1 reductases were 
measured spectrophotometrically (Hitachi model 
100-40) at 30°C in the presence of 5 mM KCN. 
The absorption changes of membrane-bound 
cytochromes b and c were monitored in a dual- 
wavelength spectrophotometer (Sigma ZW-II) 
equipped with a rapid mixing apparatus (mixing 
time 0.2-0.3 s). Optical difference spectra were 
obtained with a Jasco UVIDEC-610 UV/VIS spec- 
trophotometer. Proteins were assayed by using the 
method of Lowry et al. [ll], and bacterio- 
chlorophyll was measured at 775 nm in acetone/ 
methanol (7 : 2, v/v) extracts as in [ 121. 
3. RESULTS 
Fig.2 shows the influence of two concentrations 
of mefloquine upon R. capsulata MR126 growing 
photosynthetically in a malate minimal medium. A 
concentration of 25 PM mefloquine completely in- 
hibited growth, and eventually caused a decrease in 
turbidity. More rapid and more extensive decrease 
in turbidity was observed at 50pM mefloquine. 
The effects of mefloquine on various respiratory 
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Fig.2. Effect of mefloquine on photosynthetic growth of 
Rhodopseudomonas capsulata MR126. Mefloquine 
(MEF), dissolved in dimethyl sulfoxide, was added at the 
time indicated by the arrow. An identical volume of 
DMSO was added to the control curve (solid line). MEF 
(25 PM, ---); MEF (50pM. -----). 
activities by membrane fragments from aerobically 
grown R. capsulata MR126 are summarized in 
table 1. It is apparent that 50 /IM mefloquine par- 
tially inhibited NADH oxidation (40% of inhibi- 
tion), the residual activity completely blocked by 
50 /rM cyanide. As shown in [13], R. capsulata is 
endowed with a branched respiratory chain leading 
Table 1 
Effects of mefloquine on various respiratory activities by membrane fragments from 
Rhodopseudomonas capsulata MR126 
Activities 
(inhibitors) 
Control + Mefloquine (50 pM) 
@equiv./h per mg protein)a 
(1) NADH oxidase 21.0 13.4 
(2) (+ KCN 50~M) 13.5 0.1 
(3) NADH-DCIP reductaseb 8.6 8.1 
(4) NADH-Q-1 reductaseb 8.5 8.5 
(5) NADH-cyt. c reductaseb 34.0 17.0 
(6) QlHz-cyt. c reductaseb 30.0 25.0 
(7) Cyt. c oxidase 13.0 12.0 
* Expressed as pequiv. of either educed electron acceptor or oxidized electron donor 
b Measured in the presence of antimycin A (10 PM) plus KCN (5 mM). Cytochrome c oxidase 
was measured as ascorbate-DAD oxidase 
Q-l, ubiquinone-1; DAD, diaminodurene; QIH~, ubiquinol-1 . Concentrations of electron 
acceptors and donors used were as follows: ascorbate, 10 mM; ubiquinone-1, 40 pM; 
ubiquinol-1, 150 PM; DCIP, 150,~M; DAD, 2OOpM; NADH, 2 mM 
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to two cyt. b-type oxidases, one responsible for 
cyt. c oxidase activity and the other for the alter- 
native (cyanide-insensitive) pathway of oxygen 
consumption. These oxidases differ in mid-point 
potentials (Em,, + 410 and + 260 mV, respectively) 
and in sensitivity to KCN (50% of inhibition with 
5 /cM and 0.5 mM KCN, respectively) [14]. Thus, 
expts l-3 of table 1 suggest hat mefloquine main- 
ly affects the alternative (cyanide-insensitive) 
oxidase-dependent respiration. A second in- 
hibitory site can also be identified at the b/c region 
of the chain. Indeed both cyt. c oxidase and 
NADH dehydrogenase activities were unaffected 
by mefloquine whereas the NADH-dependent cyt. 
c reduction was 50% blocked by the antimalarial 
drug. Expt 6 of table 1 shows that 
ubiquinol-1-cyt.c reductase is largely insensitive to 
mefloquine. This result may be due to a bypass of 
the endogenous electron transport chain operated 
by the exogenous artificial redox couple. Addi- 
tional experiments revealed 50% inhibition of the 
alternative oxidase-dependent respiration at 15 ,uM 
mefloquine (not shown). 
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Fig.3. Effects of antimycin A, myxothiazol and 
mefloquine on the reduction kinetics of b- and c-type 
cytochromes in membrane fragments from R. cap.sufufu 
MR126. The traces in a and b show reduction of cyt. b 
and c (monitored at 560-575 nm and 551-540 nm, 
respectively). C, control; AA, antimycin A; QrHz, 
ubiquinol; MYXO, myxothiazol; MEF, mefloquine. 
Additions: AA, 20 PM; MYXO, 18 ,uM; MEF, 20 /cM; 
QrH2, 150,uM. Membranes (=l mg/ml) were suspended 
at pH 7.2 in 50 mM Hepes, 5 mM MgC12 buffer 
Fig.4. Effects of antimycin A, myxothiazol and 
mefloquine on the reduction kinetics of b- and c-type 
cytochromes in membranes from Pseudomonas cichorii. 
The traces in a and b show reduction of cyt. b and c 
(monitored at 561-575 nm and 551-540 nm, 
respectively). Non-standard abbreviations, inhibitors 
concentration and experimental conditions as given in 
containing 5 mM KCN. fig.3. Protein concentration was 1.5 mg/ml. 
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The traces in fig.3 represent the patterns of 
cytochromes b (560-575 nm) and c (551-540 nm) 
reduction in membranes from R. capsulata MR126 
as a function of mefloquine, myxothiazol and an- 
timycin A concentration. It is apparent that 
following the addition of ubiquinol-1 (150 PM) to 
membranes pretreated with 5 mM KCN and ox- 
idized by 10 /IM ferricyanide, reduction of a large 
amount of the total dithionite-reducible b and c 
cytochromes was achieved in about 0.2-0.3 s. In 
the presence of either antimycin A (20 pM), myx- 
othiazol (18 PM), or mefloquine (20,uM) no ap- 
preciable change of the reduction kinetics of 
cytochromes b was observed whereas opposite 
synergistic effects could be induced by the presence 
of either antimycin A plus mefloquine or myx- 
othiazol plus mefloquine. In the former case 
20-309’0 extra b-type reduction was observed, and 
in the latter cyt. b reduction was drastically 
blocked. The effects of these inhibitors on the 
reduction kinetics of c-type cytochromes indicated 
that myxothiazol is highly effective in inhibiting 
reduction of cyt. c in contrast to antimycin A and 
561-575nm 
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Volume 183, number 2 FEBS 
mefloquinone which show the same inhibitory ef- 
fect as percentage of cyt. c reduced but different 
kinetic patterns (cf. traces AA and MEF in fig.3). 
Slightly different results were obtained with 
plasma membranes from P. cichorii, a phyto- 
pathogenic obligate aerobe, in which a branched 
respiratory chain similar to that found in R. cap- 
sulata has recently been shown to operate [6]. As 
shown in fig.4a and b, mefloquine (20pM) in- 
hibited cyt. b reduction and induced an extra b- 
type reduction in the presence of antimycin A 
whereas it had no effect on cyt. c reduction. 
It has been reported that in the presence of an- 
timycin A the absorption maximum of dithionite- 
reduced cytochromes b is shifted by 2-3 nm to 
longer wavelengths ([15], but see also [16]). Fig.5 
shows that membranes from R. sphaeroides re- 
duced by dithionite at slightly acidic pH (pH 5.8) 
present a difference spectrum with a red-shift 
peaking at 562.5 nm (one minimum at 557 nm) 
t 
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Fig.5. The spectral change induced by mefloquine and 
by antimycin A in dithionite-reduced R. sphaeroides R26 
membrane particles. Membranes were diluted at a 
concentration of 0.1 mg bacteriochlorophyWm1 
equivalent o approx. 3.5 mg protein/ml in either 
50 mM Mes, 5 mM MgClz (pH 5.8) buffer or 50 mM 
Hepes, 5 mM MgC12 (pH 7.2) buffer and reduced with 
addition of solid dithionite. After the baseline had been 
recorded (not shown) either antimycin A (20/rM) or 
mefloquine (25 PM) was added to the sample cuvette. 
Spectrophotometer settings were as follows: t, 25T; 
bandwidth, 1 nm; time constant, 0.5 s; scanning speed, 
20 nm/min; photometer scale, 0.03 A. 
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when treated with antimycin A (20,uM) (lower 
trace). The upper trace of fig.5 demonstrates that 
mefloquine (25 PM) induced a dramatic spectral 
variation of cytochromes b with a minimum at 
561 nm and a maximum at 569.5 nm (pH 7.2). It 
is noteworthy that differently from antimycin A, 
the mefloquine-induced red-shift was not observed 
at acidic pH values. 
4. DISCUSSION AND CONCLUSIONS 
This study clearly shows that mefloquine, a 
quinoline-4-methanol antimalarial drug, is an ef- 
fective inhibitor of electron transport in bacterial 
respiratory systems. Testing the sensitivity of 
several electron transport reaction steps toward 
this antimalarial drug, it has been found that only 
those systems comprising the ubiquinol-(cyanide 
insensitive) oxidase and the b/c segment of the 
chain were affected by mefloquine. The spectral 
change induced by mefloquine in dithionite- 
reduced membranes from R. sphaeroides sug- 
gested that the binding site(s) of the drug is pro- 
bably cyt. b in the b/c complex (shown in fig.5). In 
both isolated b/c complex and chromatophore 
membranes from R. sphaeroides, a spectral shift 
induced by antimycin A of the peaks of 
cytochrome b has been linked to close association 
between the antibiotic and the heme of cyt. b-561, 
one of the two hemes of the ubiquinol-cyt. c ox- 
idoreductase complex, i.e., cyt. b-561 and cyt. 
b-566 [17]. As shown in fig.5, the spectral change 
caused by mefloquine does not resemble that 
found with antimycin A. In addition, the red-shifts 
induced by mefloquine and antimycin A were best 
observable at quite different pH values (pH 7.2 
and 5.8, respectively) and they seemed to be in- 
dependent of each other (not shown). These results 
might therefore indicate a binding effect of meflo- 
quine at a site perturbing the spectroscopic proper- 
ties of b-566 heme. The latter suggestion is in line 
with the kinetic reduction patterns of cyt. b and c 
reported in figs 3 and 4. Indeed, in the absence of 
inhibitors, ubiquinol-1 rapidly reduced cyt. c 
(70%) and approx. 40% of the dithionite-reducible 
b. This b consists solely of cyt. b-562, owing to the 
relatively high potential of the quinone/quinol 
couple. Mefloquine together with antimycin A 
caused an increase in cyt. b reduction by 
ubiquinol-I but largely blocked reduction of cyt. b 
343 
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when used in combination with myxothiazol. 
Likewise, if myxothiazol was added together with 
antimycin A the combination of these inhibitors 
drastically blocked reduction of cyt. b. In this con- 
nection it has been shown 1171 that myxothiazol, 
which contains /?-methoxyacrylate as structural 
segment, binds to cyt. b-566 and blocks electron 
flow to both cyt. b-566 and Rieske iron-sulphur 
protein at a redox centre defined as Qo according 
to the protonmotive ‘Q-cycle’ scheme [ 18-201. In 
contrast, antimycin A blocks reduction of ubi- 
quinone by cyt. b-562 at a redox centre defined as 
Qi through binding to cyt. b-562 as indicated by a 
red-shift of the cyt. b-562 absorbance signal [ 151. 
The experimental data described above suggest 
that the effects produced by mefloquine on 
respiration by various bacterial systems are dif- 
ferent from those induced by antimycin A and 
myxothiazol. The hypothesis sustained here is that 
mefloquine interacts at a ubiquinol oxidase site 
which is probably shared by the alternative oxidase 
branch and the b/c complex of the chain. Unlike 
myxothiazol, mefloquine does not affect the for- 
mation of the ubisemiquinone Q’ - at the redox 
centre Qo, since it does not inhibit the oxidant- 
induced extra b-type reduction (not reported) but 
does bring about an extra reduction of b-type 
cytochromes only in combination with antimycin 
A. The latter phenomenon might reflect a 
mefloquine-induced shift to higher values of &,,,7 
for cyt. b-566 so as to provide reduction of both 
cyt. b-566 and b-562 by the quinone/quinol couple 
as suggested by preliminary results from redox 
titrations of b-type cytochromes (Zannoni, in 
preparation). Thus, the effect of mefloquine on 
the electron transport through the b/c complex 
must be a consequence of the fact that the b/c 
redox components are relatively close to each 
other, and that their proteins may form the reac- 
tion site at which ubiquinol from the pool is oxi- 
dized [17-211. Further studies will clearly be 
necessary to determine whether other redox com- 
ponents in addition to cyt. b-566, e.g., Rieske Fe-S 
centre, are spectrally and/or thermodynamically 
affected by mefloquine. 
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